Monica Bocchia Selected Research

Monica Bocchia Research Topics

Disease

38	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2023 - 07/2002
22	Multiple Myeloma 01/2023 - 12/2005
16	Neoplasms (Cancer) 02/2024 - 02/2014
13	Lymphoma (Lymphomas) 10/2023 - 03/2003
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2023 - 08/2014
8	Residual Neoplasm 08/2023 - 02/2014
8	COVID-19 02/2023 - 01/2020
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024 - 04/2016
7	Primary Myelofibrosis (Myelosclerosis) 12/2023 - 08/2006
7	Disease Progression 10/2023 - 11/2006
7	Leukemia 10/2021 - 01/2012
6	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2024 - 06/2008
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2022 - 01/2005
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 02/2010
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2023 - 06/2016
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2023 - 12/2018
5	Philadelphia Chromosome 01/2023 - 01/2004
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2012
5	Hematologic Neoplasms (Hematological Malignancy) 12/2022 - 02/2014
5	Pathologic Complete Response 01/2021 - 10/2005
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2020 - 01/2015
4	Infections 01/2022 - 11/2008
3	Blast Crisis (Blast Phase) 12/2023 - 01/2007
3	Anemia 12/2023 - 09/2020
3	VEXAS syndrome 12/2023 - 01/2022
3	Thrombocytopenia (Thrombopenia) 10/2023 - 03/2017
3	Hairy Cell Leukemia 01/2023 - 01/2018
3	T-Cell Lymphoma (Lymphoma, T Cell) 10/2021 - 12/2013
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2017
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2017 - 06/2015
2	Hemorrhage 10/2023 - 03/2017
2	Hypertension (High Blood Pressure) 01/2023 - 07/2020
2	Exanthema (Rash) 01/2022 - 01/2019
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 09/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018 - 08/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2017 - 12/2005
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2016 - 09/2015
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 08/2006 - 10/2004

Drug/Important Bio-Agent (IBA)

22	Rituximab (Mabthera)FDA Link 12/2023 - 06/2008
18	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2008
16	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 10/2003
10	nilotinib FDA Link 06/2023 - 11/2012
9	ruxolitinibIBA 12/2023 - 01/2020
9	fludarabineIBA 12/2023 - 03/2003
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 04/2014
8	Bortezomib (Velcade)FDA Link 01/2017 - 03/2007
7	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 02/2010
7	Lenalidomide (CC 5013)FDA Link 01/2023 - 02/2010
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2008
5	venetoclaxIBA 11/2023 - 01/2020
5	ibrutinibIBA 11/2023 - 01/2017
4	Prednisone (Sone)FDA LinkGeneric 01/2024 - 08/2014
4	Hemoglobins (Hemoglobin)IBA 12/2023 - 01/2023
4	Proteasome InhibitorsIBA 01/2023 - 06/2016
4	Dasatinib (BMS 354825)FDA Link 01/2023 - 01/2016
4	Phosphotransferases (Kinase)IBA 01/2020 - 11/2012
3	eltrombopag FDA Link 10/2023 - 03/2017
3	Bendamustine Hydrochloride FDA Link 10/2023 - 01/2019
3	Monoclonal AntibodiesIBA 11/2022 - 01/2021
3	daratumumabIBA 03/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2021
3	Inosine Triphosphate (ITP)IBA 09/2020 - 04/2010
3	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2018 - 10/2005
3	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 10/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2018 - 08/2014
3	Vincristine (Oncovin)FDA LinkGeneric 12/2018 - 08/2014
3	Protein Subunit VaccinesIBA 02/2014 - 07/2002
3	Thalidomide (Thalomid)FDA Link 01/2014 - 12/2005
2	SteroidsIBA 12/2023 - 01/2022
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2023 - 08/2006
2	pixantrone (BBR 2778)IBA 08/2023 - 05/2022
2	Biosimilar PharmaceuticalsIBA 02/2023 - 08/2022
2	CT-P10IBA 02/2023 - 08/2022
2	carfilzomibIBA 01/2023 - 10/2022
2	EnzymesIBA 01/2023 - 01/2022
2	AntigensIBA 01/2022 - 01/2012
2	Nerve Growth Factor (NGF)IBA 01/2022 - 09/2020
2	ponatinibIBA 01/2022 - 09/2018
2	COVID-19 VaccinesIBA 01/2022 - 10/2021
2	AnthracyclinesIBA 10/2021 - 06/2016
2	oxidized low density lipoproteinIBA 08/2021 - 09/2015
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 11/2010
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 06/2013
2	Erythropoietin FDA Link 09/2020 - 06/2013
2	Interleukin-2 (IL2)IBA 01/2019 - 04/2016
2	amsonic acid (DAS)IBA 01/2018 - 01/2016
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 10/2015
2	liposomal doxorubicin (Doxil)FDA Link 06/2016 - 02/2010
2	Interferon-alpha (Interferon Alfa)IBA 08/2010 - 01/2004
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2008 - 01/2007
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2007 - 10/2005
1	Histone Deacetylase InhibitorsIBA 04/2024
1	Interleukin-9 (Interleukin 9)IBA 02/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024

Therapy/Procedure

33	Therapeutics 12/2023 - 10/2003
7	Drug Therapy (Chemotherapy) 05/2023 - 12/2005
4	Radiotherapy 10/2020 - 08/2014
3	Stem Cell Transplantation 01/2021 - 10/2005
2	Immunotherapy 01/2023 - 04/2016